Literature DB >> 29889273

Impact of Interethnic Difference of Collateral Angioarchitectures on Prevalence of Hemorrhagic Stroke in Moyamoya Disease.

Satoshi Hori1,2, Daina Kashiwazaki1, Shusuke Yamamoto1, Güliz Acker2,3, Marcus Czabanka2, Naoki Akioka1, Naoya Kuwayama1, Peter Vajkoczy2, Satoshi Kuroda1.   

Abstract

BACKGROUND: Fragile, dilated moyamoya vessels are the main source of hemorrhagic stroke in moyamoya disease (MMD). However, the prevalence of hemorrhagic stroke largely differs between Asian and western countries, although the underlying pathophysiology has not been clarified.
OBJECTIVE: To systematically analyze the difference of collateral angioarchitectures between Japanese and European Caucasians with MMD.
METHODS: This study included 71 patients with MMD, including Japanese (n = 41) and European Caucasians (n = 30). Using preoperative cerebral angiography, the developments of lenticulostriate artery (LSA), anterior choroidal artery (AChoA), posterior communicating artery (PcomA), and posterior choroidal artery (PChoA) were precisely evaluated, and ethic difference was analyzed in terms of patients' age and the onset type.
RESULTS: Cerebral angiography demonstrated that the marked dilatation of AChoA and PChoA were significantly more remarkable in Japanese than in European Caucasians (P = .004 and P = .002, respectively). Ageing advanced the dilatation and extension of PChoA and PcomA, and diminished the development of LSA in Japanese patients (P < .001, P = .03, and P = .03, respectively). European Caucasian patients did not have the specific dilated pattern like Japanese patients.
CONCLUSION: The marked dilatation of PChoA and PcomA is considered a powerful predictive marker of hemorrhage in MMD. Collateral channels spontaneously shift from the anterior to posterior circulation in Japanese patients during ageing but not in European Caucasian patients. These different dilation patterns of the collateral pathway may be associated with an ethnic difference of the clinical onset type in MMD.
Copyright © 2018 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Moyamoya disease; choroidal artery; hemorrhagic onset; moyamoya vessels; racial difference

Mesh:

Year:  2019        PMID: 29889273     DOI: 10.1093/neuros/nyy236

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Imaging features of adult moyamoya disease patients with anterior intracerebral hemorrhage based on high-resolution magnetic resonance imaging.

Authors:  Jiali Xu; Gary B Rajah; Houdi Zhang; Cong Han; Xuxuan Shen; Bin Li; Zhengxing Zou; Wenbo Zhao; Changhong Ren; Guiyou Liu; Yuchuan Ding; Qi Yang; Sijie Li; Xunming Ji
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-29       Impact factor: 6.960

2.  Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.

Authors:  Haruto Uchino; Masaki Ito; Ken Kazumata; Yuka Hama; Shuji Hamauchi; Shunsuke Terasaka; Hidenao Sasaki; Kiyohiro Houkin
Journal:  BMC Med Genomics       Date:  2018-08-29       Impact factor: 3.063

3.  Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease.

Authors:  Kaijiang Kang; Jingjing Lu; Yi Ju; Ruijun Ji; Dandan Wang; Yuan Shen; Lebao Yu; Bin Gao; Dong Zhang; Xingquan Zhao
Journal:  Front Neurol       Date:  2020-05-07       Impact factor: 4.003

4.  Development and natural course of lateral posterior choroidal artery aneurysms arising from fragile choroidal collaterals in moyamoya disease: illustrative cases.

Authors:  Tomoaki Suzuki; Hitoshi Hasegawa; Kouichirou Okamoto; Kazuhiro Ando; Kohei Shibuya; Haruhiko Takahashi; Shoji Saito; Makoto Oishi; Yukihiko Fujii
Journal:  J Neurosurg Case Lessons       Date:  2021-04-12

5.  Angiographic study of the transdural collaterals at the anterior cranial fossa in patients with Moyamoya disease.

Authors:  Kun Hou; Guichen Li; Yunbao Guo; Baofeng Xu; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

Review 6.  The Genetic Basis of Moyamoya Disease.

Authors:  R Mertens; M Graupera; H Gerhardt; A Bersano; E Tournier-Lasserve; M A Mensah; S Mundlos; P Vajkoczy
Journal:  Transl Stroke Res       Date:  2021-09-16       Impact factor: 6.829

Review 7.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.